Innovative public-private collaboration launches to tackle antibiotic research Full Text
GlaxoSmithKline, 05/25/2012
GlaxoSmithKline and AstraZeneca welcomed the launch of a pioneering approach to antibiotic research in Europe that will see pharmaceutical and biotechnology companies working alongside public partners to tackle the rising threat from antibiotic resistance and address some of the key barriers to the development of effective antibiotics.



